Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3Q7J

Engineered Thermoplasma Acidophilum F3 factor mimics human aminopeptidase N (APN) as a target for anticancer drug development

3Q7J の概要
エントリーDOI10.2210/pdb3q7j/pdb
分子名称Tricorn protease-interacting factor F3, ZINC ION, L-phenylalanyl-N6-[(benzyloxy)carbonyl]-N1-hydroxy-L-lysinamide, ... (4 entities in total)
機能のキーワードtrf3, inhibitor fbo, aminopeptidase, inhibitor binding, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
由来する生物種Thermoplasma acidophilum
細胞内の位置Cytoplasm: O93655
タンパク質・核酸の鎖数2
化学式量合計179530.81
構造登録者
Su, J.,Wang, Q.,Feng, J.,Zhang, C.,Zhu, D.,We, T.,Xu, W.,Gu, L. (登録日: 2011-01-05, 公開日: 2011-07-27, 最終更新日: 2023-11-01)
主引用文献Su, J.,Wang, Q.,Feng, J.,Zhang, C.,Zhu, D.,Wei, T.,Xu, W.,Gu, L.
Engineered Thermoplasma acidophilum factor F3 mimics human aminopeptidase N (APN) as a target for anticancer drug development
Bioorg.Med.Chem., 19:2991-2996, 2011
Cited by
PubMed Abstract: Human aminopeptidase N (hAPN) is an appealing objective for the development of anti-cancer agents. The absence of mammalian APN experimental structure negatively impinges upon the progression of structure-based drug design. Tricorn interacting factor F3 (factor F3) from Thermoplasma acidophilum shares 33% sequence identity with hAPN. Engineered factor F3 with two point directed mutations resulted in a protein with an active site identical to hAPN. In the present work, the engineered factor F3 has been co-crystallized with compound D24, a potent APN inhibitor introduced by our lab. Such a holo-form experimental structure helpfully insinuates a more bulky pocket than Bestatin-bound Escherichia coli APN. This evidence discloses that compound D24 targetting the structure of E. coli APN cannot bind to the activity cleft of factor F3 with high affinity. Thus, there is a potential risk of inefficiency to design hAPN targeting drug while using E. coli APN as the target model. We do propose here now that engineered factor F3 can be employed as a reasonable alternative of hAPN for drug design and development.
PubMed: 21493078
DOI: 10.1016/j.bmc.2011.03.028
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.91 Å)
構造検証レポート
Validation report summary of 3q7j
検証レポート(詳細版)ダウンロードをダウンロード

237423

件を2025-06-11に公開中

PDB statisticsPDBj update infoContact PDBjnumon